verified SJR 0,479 · Q3 • database Scopus / SJR & Web of Science indexed

United Kingdom · Maney Publishing

workspace_premium Q3 — Medicine (miscellaneous) lock Subscription

Journal of Chemotherapy

Journal of Chemotherapy is a journal indexed in SJR in Medicine (miscellaneous) and Infectious Diseases with an H index of 59. It has an SJR impact factor of 0,479 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,479.

Journal of Chemotherapy focuses its scope in these topics and keywords: drug, multicenter, randomized, susceptibility, uncomplicated, septicemiaone, antimicrobial, voriconazole, surveillance, moxifloxacin, ...

ISSN: 1120-009X

Publisher: Maney Publishing

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,479 Q3

H-index 59

Acceptance rate pie_chart

30% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,479

H-index

Docs (year)

134

Docs 3y

214

Total refs

5370

Cites 3y

372

Citable 3y

202

Cites/Doc 2y

1.74

Ref/Doc

40.07

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Antimicrobial Resistance among Uropathogens Responsible for Community-Acquired Urinary Tract Infections in an Italian Community

Vascular Catheter-Associated Infections: A Microbiological and Therapeutic Update

Comparison of Five Different Methods for Detection of SHV Extended-Spectrum beta-Lactamases

Comparison of Cefaclor and Cefuroxime Axetil in the Treatment of Acute Otitis Media with Effusion in Children Who Failed Amoxicillin Therapy

ComparativeIn VitroActivity of Silver Sulfadiazine, Alone and in Combination with Cerium Nitrate, Against Staphylococci and Gram-Negative Bacteria

Clinical Efficacy and Tolerability of Caspofungin in a Renal Transplant Patient withAspergillus flavusLung Infection: Case Report

Clinical and Microbiological Efficacy of Colistin Therapy Alone or in Combination as Treatment for Multidrug ResistantPseudomonas aeruginosaDiabetic Foot Infections with or Without Osteomyelitis

Cardiotoxicity During Chemotherapy Treatment with 5-Fluorouracil and Cisplatin

Brodimoprim: Therapeutic Efficacy and Safety in the Treatment of Bacterial Infections

beta-Lactam and Macrolide Resistance and Serotype Distribution amongStreptococcus pneumoniaeIsolates from Saudi Arabia

Assessment of Presystemic Factors on the Oral Bioavailability of Rifampicin Following Multiple Dosing

Antimicrobial Susceptibility Patterns inPseudomonas aeruginosa:Data from a Multicenter Intensive Care Unit Surveillance Study (ISS) in the United States

SHOW MORE ARTICLES

Antimicrobial Resistance and Prevalence of Extended Spectrum beta-Lactamase Among Clinical Isolates of Gram-Negative Bacteria in Riyadh

A Case Series of Macrolide Treatment Failures in Community Acquired Pneumonia

Antimicrobial resistance among Gram-positive pathogens in Saudi Arabia

Antimicrobial Resistance Among Clinical Isolates ofStreptococcus pneumoniaeIsolated in Four Southern European Countries (ARISE Project) from Adult Patients: Results from the Cefditoren Surveillance Program

Antimicrobial Action and Pharmacokinetics/Pharmacodynamics: The Use of AUIC to Improve Efficacy and Avoid Resistance

Antifungal Activity of Voriconazole (UK-109,496), Fluconazole and Amphotericin B Against HematogenousCandida kruseiInfection in Neutropenic Guinea Pig Model

Antibiotic Therapy againstPseudomonas aeruginosain Cystic Fibrosis

Antibacterial Resistance inStreptococcus pneumoniaeandHaemophilus influenzaefrom Italy and Spain: Data from the PROTEKT Surveillance Study, 1999-2000

Anaerobic Bacteria in Postsurgical Infections: Isolation Rate and Antimicrobial Susceptibility

AM-7359 -a Novel Oxazolidinone with Low Resistance Potential and Potent Activity Against Drug Resistant Pathogens

A Review of the Microbiology of Amoxycillin/Clavulanic Acid Over the 15 Year Period 1978-1993

A Pharmacodynamic Simulation to Assess Tigecycline Efficacy for Hospital-Acquired Pneumonia Compared with Other Common Intravenous Antibiotics

FAQs

Journal of Chemotherapy has an SJR of 0,479 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Journal of Chemotherapy is 30%.

Journal of Chemotherapy

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Journal of Chemotherapy?

What is the APC / publication cost?

What is the acceptance rate?